Grants.govNational Institutes of Health

National Cancer Institute's Investigator-Initiated Early Phase Clinical Trials for Cancer Treatment and Diagnosis (R01 Clinical Trial Required)

Posted Nov 12, 2024·open

AGENCY

HHS-NIH11

PROGRAM

Discretionary

AMOUNT

Up to $500K

CLOSES

Jan 7, 2027

Apply on Grants.gov ↗More info from funder ↗

Description

Through this Notice of Funding Opportunity, the National Cancer Institute (NCI) seeks research projects that implement early phase (Phase 0, I, and II) investigator-initiated clinical trials focused on cancer-targeted diagnostic and therapeutic interventions of direct relevance to the research mission of DCTD and OHAM. The proposed project must involve at least 1 clinical trial related to the scientific interests of one or more of the following research programs: Cancer Therapy Evaluation Program, Cancer Imaging Program, Cancer Diagnosis Program, Radiation Research Program, Complementary and Alternative Medicine Program and/or the HIV and AIDS Malignancies Research Programs. Applicants may propose to conduct an early phase trial by itself, or in combination with another research aim(s) as appropriate.

Eligibility

Others (see text field entitled "Additional Information on Eligibility" for clarification); Special district governments; City or township governments; Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education; County governments; Private institutions of higher education; Public and State controlled institutions of higher education; Native American tribal organizations (other than Federally recognized tribal governments); Public housing authorities/Indian housing authorities; Independent school districts; For profit organizations other than small businesses; Native American tribal governments (Federally recognized); State governments; Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education; Small businesses

Contact

National Institutes of Health

grantsinfo@nih.gov

301-402-2541

Additional details

Funding instrument: Grant
Cost sharing required: No
Archived: Feb 12, 2027

Opportunity number: PAR-25-081

Search this number on Grants.gov for the official listing.